Lundbeck
HLUN-B.CO
#2719
Rank
โ‚น584.81 B
Marketcap
โ‚น589.45
Share price
1.36%
Change (1 day)
61.29%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): โ‚น52.79

According to Lundbeck's latest financial reports the company's current EPS (TTM) is โ‚น57.00. an increase over its 2024 EPS that were of โ‚น41.16.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025โ‚น47.1214.5%
2024โ‚น41.1629.29%
2023โ‚น31.8323.09%
2022โ‚น25.8637.26%
2021โ‚น18.84-84.61%
2020โ‚น122.43-24.61%
2019โ‚น162.39-42.06%
2018โ‚น280.2740.7%
2017โ‚น199.21146.26%
2016โ‚น80.89-120.48%
2015-โ‚น394.903231.32%
2014-โ‚น11.85-115.78%
2013โ‚น75.11-23.36%
2012โ‚น98.00-48.01%
2011โ‚น188.52-9.68%
2010โ‚น208.7413.72%
2009โ‚น183.5524.32%
2008โ‚น147.65-6.05%
2007โ‚น157.1581.77%
2006โ‚น86.45-16.76%
2005โ‚น103.87-17.58%
2004โ‚น126.02